[ Price : $8.95]
Johnson & Johnson discontinues a Phase 2 study evaluating mosnodenvir for preventing dengue virus in adults aged 18-65 years.[ Price : $8.95]
FDA says the shortage of Lillys Mounjaro and Zepbound has been resolved but other similar products remain in short supply.[ Price : $8.95]
FDA lifts a partial clinical hold on Avidity Biosciences delpacibart etedesiran (del-desiran/AOC 1001) that is being evaluated for...[ Price : $8.95]
FDA has released the form FDA-483 with five observations from an inspection at the Lakewood, CO-based BSO outsourcing facility.[ Price : $8.95]
FDA releases a list of 18 drug products for which there was a potential signal of serious risks or new safety information in the s...[ Price : $8.95]
FDA grants Amphix Bio a breakthrough device designation for its drug-device combination product for bone regeneration.[ Price : $8.95]
FDA approves Bristol Myers Squibbs Opdivo (nivolumab) in combination with platinum-doublet chemotherapy as neoadjuvant treatment o...[ Price : $8.95]
FDA denies an Amneal Pharmaceuticals petition asking the agency to take several actions involving Provells Euthyrox (levothyroxine...